Please use this identifier to cite or link to this item: doi:10.22028/D291-42507
Title: Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay
Author(s): Gampfer, Tanja M.
Schütz, Victoria
Schippers, Philip
Rasheed, Sari
Baumann, Jonas
Wagmann, Lea
Pulver, Benedikt
Westphal, Folker
Flockerzi, Veit
Müller, Rolf
Meyer, Markus R.
Language: English
Title: Journal of Pharmaceutical and Biomedical Analysis
Volume: 245
Publisher/Platform: Elsevier
Year of Publication: 2024
Free key words: New psychoactive substances
Pooled human liver S9 fraction
Zebrafish larvae
LC-HRMS/MS
HepG2
Cytotoxicity
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: The continuous emergence of new psychoactive substances (NPS) attracted a great deal of attention within recent years. Lately, the two hallucinogenic NPS 1cP-LSD and 4-AcO-DET have appeared on the global market. Knowledge about their metabolism to identify potential metabolic targets for analysis and their cytotoxic properties is lacking. The aim of this work was thus to study their in vitro and in vivo metabolism in pooled human liver S9 fraction (pHLS9) and in zebrafish larvae (ZL) by means of liquid chromatography-high-resolution tandem mass spectrometry. Monooxygenases involved in the initial metabolic steps were elucidated using recombinant human isozymes. Investigations on their cytotoxicity were performed on the human hepatoma cell line HepG2 using a multiparametric, fluorescence-based high-content screening assay. This included measurement of CYP-enzyme mediated effects by means of the unspecific CYP inhibitor 1-aminbenzotriazole (ABT). Several phase I metabolites of both compounds and two phase II metabolites of 4-AcO-DET were produced in vitro and in vivo. After microinjection of 1cP-LSD into the caudal vein of ZL, three out of seven metabolites formed in pHLS9 were also detected in ZL. Twelve 4-AcO-DET metabolites were identified in ZL after exposure via immersion bath and five of them were found in pHLS9 incubations. Notably, unique metabolites of 4-AcO-DET were only produced by ZL, whereas 1cP-LSD specific metabolites were found both in ZL and in pHLS9. No toxic effects were observed for 1cP-LSD and 4-AcO-DET in HepG2 cells, however, two parameters were altered in incubations containing 4-AcO-DET together with ABT compared with incubations without ABT but in concentrations far above expected in vivo concentration. Further investigations should be done with other hepatic cell lines expressing higher levels of CYP enzymes.
DOI of the first publication: 10.1016/j.jpba.2024.116187
URL of the first publication: https://doi.org/10.1016/j.jpba.2024.116187
Link to this record: urn:nbn:de:bsz:291--ds-425076
hdl:20.500.11880/38142
http://dx.doi.org/10.22028/D291-42507
ISSN: 0731-7085
Date of registration: 1-Aug-2024
Description of the related object: Supporting information
Related object: https://ars.els-cdn.com/content/image/1-s2.0-S0731708524002279-mmc1.docx
Faculty: M - Medizinische Fakultät
NT - Naturwissenschaftlich- Technische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
NT - Pharmazie
Professorship: M - Prof. Dr. Veit Flockerzi
M - Prof. Dr. Markus Meyer
NT - Prof. Dr. Rolf Müller
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
1-s2.0-S0731708524002279-main.pdf1,62 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons